| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
|
| | L-threo-1-Phenyl-2-hexadecanoylamino-3-morpholino-1-propanol HCl Basic information |
| | L-threo-1-Phenyl-2-hexadecanoylamino-3-morpholino-1-propanol HCl Chemical Properties |
| Boiling point | 642.8±55.0 °C(Predicted) | | density | 1.005±0.06 g/cm3(Predicted) | | pka | 13.60±0.20(Predicted) |
| | L-threo-1-Phenyl-2-hexadecanoylamino-3-morpholino-1-propanol HCl Usage And Synthesis |
| Uses | L-threo-PPMP is a GlcT (UDP-Glc: Ceramide β1,1glucosyltransferase) inhibitor. L-threo-PPMP inhibits glycosphingolipid biosynthesis and induces apoptosis. L-threo-PPMP has anti-cancer activity[1]. | | Definition | ChEBI: (1S,2S)-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol is an N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide in which both stereocentres have S configuration. It is an enantiomer of a (1R,2R)-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol. | | References | [1] Subhash Basu, et al. Apoptosis of human carcinoma cells in the presence of inhibitors of glycosphingolipid biosynthesis: I. Treatment of Colo-205 and SKBR3 cells with isomers of PDMP and PPMP. Glycoconj J. 2004;20(3):157-68. DOI:10.1023/B:GLYC.0000024254.64450.8b |
| | L-threo-1-Phenyl-2-hexadecanoylamino-3-morpholino-1-propanol HCl Preparation Products And Raw materials |
|